Evelo Biosciences Stock Market Capitalization
Evelo Biosciences fundamentals help investors to digest information that contributes to Evelo Biosciences' financial success or failures. It also enables traders to predict the movement of Evelo Pink Sheet. The fundamental analysis module provides a way to measure Evelo Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evelo Biosciences pink sheet.
Evelo |
Evelo Biosciences Company Market Capitalization Analysis
Evelo Biosciences' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Evelo Biosciences Market Capitalization | 7 M |
Most of Evelo Biosciences' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evelo Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Evelo Biosciences is about 7 M. This is 99.95% lower than that of the Biotechnology sector and 99.85% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.96% higher than that of the company.
Evelo Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evelo Biosciences' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics of similar companies.Evelo Biosciences is currently under evaluation in market capitalization category among its peers.
Evelo Fundamentals
Return On Equity | -62.33 | ||||
Return On Asset | -0.83 | ||||
Current Valuation | 23.69 M | ||||
Shares Outstanding | 18.93 M | ||||
Shares Owned By Insiders | 0.23 % | ||||
Shares Owned By Institutions | 83.13 % | ||||
Number Of Shares Shorted | 430.1 K | ||||
Price To Earning | (4.19) X | ||||
Price To Book | 3.51 X | ||||
EBITDA | (108.41 M) | ||||
Net Income | (114.53 M) | ||||
Cash And Equivalents | 92.01 M | ||||
Cash Per Share | 0.85 X | ||||
Total Debt | 51.14 M | ||||
Debt To Equity | 1.55 % | ||||
Current Ratio | 4.53 X | ||||
Book Value Per Share | (1.42) X | ||||
Cash Flow From Operations | (101.23 M) | ||||
Short Ratio | 0.42 X | ||||
Earnings Per Share | (15.64) X | ||||
Target Price | 10.0 | ||||
Number Of Employees | 66 | ||||
Beta | 1.74 | ||||
Market Capitalization | 7 M | ||||
Total Asset | 64.44 M | ||||
Retained Earnings | (529.22 M) | ||||
Working Capital | 39.18 M | ||||
Current Asset | 49.29 M | ||||
Current Liabilities | 4.32 M | ||||
Z Score | -16.24 | ||||
Net Asset | 64.44 M |
Pair Trading with Evelo Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evelo Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Southern could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Southern when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Southern - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Southern Company to buy it.
The correlation of Southern is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Southern moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Southern moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Southern can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |